Biomarkers in Routine Heart Failure Clinical Care

Sunil K. Nadar*, Muhammad Mujtaba Shaikh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

72 Citations (Scopus)


Heart failure is a clinical condition with complex pathophysiology that involves many different processes. Diagnosis is often difficult in patients presenting for the first time with breathlessness. Many biomarkers have been identified that are elevated in heart failure and their role in assessing prognosis has also been investigated. However, at present the natriuretic peptides appear to be the gold standard biomarker against which the other biomarkers are compared. In this review we will examine the evidence behind the other biomarkers for use in heart failure patients and the current guidelines for their use.

Original languageEnglish
Pages (from-to)50-56
Number of pages7
JournalCardiac Failure Review
Issue number1
Publication statusPublished - 2019


  • Acute heart failure
  • biomarkers
  • chronic heart failure
  • diagnosis
  • natriuretic peptides
  • prognosis
  • troponin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this